Lexicon Pharmaceuticals to Host Second Quarter 2024 Financial Results Conference Call and Webcast on August 1, 2024

Company Overview - Lexicon Pharmaceuticals, Inc. is a biopharmaceutical company focused on pioneering medicines that transform patients' lives through innovative drug discovery and development [3]. - The company has studied nearly 5,000 genes through its Genome5000™ program, identifying over 100 protein targets with significant therapeutic potential across various diseases [3]. Product Pipeline - Lexicon is commercially launching INPEFA® (sotagliflozin) in the United States and has a pipeline of promising drug candidates in discovery and clinical and preclinical development targeting neuropathic pain, diabetes, metabolism, and other indications [3]. Financial Information - Lexicon is set to release its second quarter 2024 financial results on August 1, 2024, after market close, followed by a conference call and live webcast to discuss the results and provide a business update [4].